Arcellx (ACLX) Shares Outstanding (Diluted Average) (2021 - 2025)

Arcellx (ACLX) recorded quarterly Shares Outstanding (Diluted Average) of $56.3 million in Q4 2025, little changed quarter-over-quarter from $56.6 million in Q3 2025, and up 5.11% on a YoY basis from $53.6 million in Q4 2024.

Arcellx (ACLX) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends

Arcellx's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $56.3 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Diluted Average) rose 5.11% year-over-year to $56.3 million; the TTM figure through Dec 2025 stood at $56.3 million (up 5.11% YoY), while the FY2025 annual figure was $56.3 million, up 5.11% from the prior year.
  • Shares Outstanding (Diluted Average) was $56.3 million for Q4 2025 at Arcellx, roughly flat from $56.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $56.6 million in Q3 2025 to a low of $337302.0 in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $37.4 million across 5 years, with a median of $47.6 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) surged 8044.59% in 2022, then climbed 4.74% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $446379.0 in 2021, then soared by 8044.59% to $36.4 million in 2022, then soared by 32.2% to $48.1 million in 2023, then increased by 11.45% to $53.6 million in 2024, then gained by 5.11% to $56.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $56.3 million (Q4 2025), $56.6 million (Q3 2025), and $56.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 56.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 56.31 Mn
Sep 30, 2025 56.59 Mn
Jun 30, 2025 56.22 Mn
Mar 31, 2025 55.26 Mn
Dec 31, 2024 53.57 Mn
Sep 30, 2024 53.37 Mn
Jun 30, 2024 53.52 Mn
Mar 31, 2024 52.76 Mn
Dec 31, 2023 48.06 Mn
Sep 30, 2023 47.78 Mn
Jun 30, 2023 47.44 Mn
Mar 31, 2023 46.77 Mn
Dec 31, 2022 36.36 Mn
Sep 30, 2022 33.81 Mn
Jun 30, 2022 28.73 Mn
Mar 31, 2022 20.76 Mn
Dec 31, 2021 446,379.00
Sep 30, 2021 422,825.00
Jun 30, 2021 437,258.00
Mar 31, 2021 337,302.00